Analyst Price Target is $3.50
▲ +53.85% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for KORU Medical Systems in the last 3 months. The average price target is $3.50, with a high forecast of $4.00 and a low forecast of $3.00. The average price target represents a 53.85% upside from the last price of $2.28.
Current Consensus is
Buy
The current consensus among 4 contributing investment analysts is to buy stock in KORU Medical Systems. This Buy consensus rating has held steady for over two years.
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the subcutaneous drug delivery market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. The company was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Read More